Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perrigo Brinzolamide/Brimonidine vs Simbrinza for Glaucoma or Ocular Hypertension
NCT04944290Phase 3Completed
- Sponsor
- Padagis
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brinzolamide, brimonidine tartrate + sodium hyaluronate in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Padagis. Started May 2021; status: completed.
02
Drugs
brinzolamidebrimonidine tartrate + sodium hyaluronate
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT04944290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04944290.